We compared patient demographics and healthcare outcomes (eg, length of stay, inpatient death, type and number of procedures, and cost of care) between COPD patients with and without alpha-1 antitrypsin deficiency. The gene discussed is PSMA6; the disease is chronic obstructive pulmonary disease.